AAAAAA

   
Results: 1-13 |
Results: 13
THE GENETIC-POLYMORPHISM OF CYP2E1 IN KOREAN HEALTHY-SUBJECTS AND HEPATOCELLULAR-CARCINOMA PATIENTS
Authors: KWON JT KIM HK KIM HS CHUNG IK PARK SH KIM SJ SOHN DR
Citation: Jt. Kwon et al., THE GENETIC-POLYMORPHISM OF CYP2E1 IN KOREAN HEALTHY-SUBJECTS AND HEPATOCELLULAR-CARCINOMA PATIENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 41-41
DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY AND PLASMA 5-FLUOROURACIL LEVELS IN KOREAN SUBJECTS
Authors: KIM HK KWON JT SOHN DR JANG IJ SHIN SG
Citation: Hk. Kim et al., DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY AND PLASMA 5-FLUOROURACIL LEVELS IN KOREAN SUBJECTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 54-54
THE GENETIC-POLYMORPHISM OF ANGIOTENSIN-CONVERTING ENZYME IN A KOREANPOPULATION
Authors: SOHN DR KWON JT KIM HK
Citation: Dr. Sohn et al., THE GENETIC-POLYMORPHISM OF ANGIOTENSIN-CONVERTING ENZYME IN A KOREANPOPULATION, Pharmacogenetics, 7(5), 1997, pp. 425-427
METABOLIC DISPOSITION OF LANSOPRAZOLE IN RELATION TO THE S-MEPHENYTOIN 4'-HYDROXYLATION PHENOTYPE STATUS
Authors: SOHN DR KWON JT KIM HK ISHIZAKI T
Citation: Dr. Sohn et al., METABOLIC DISPOSITION OF LANSOPRAZOLE IN RELATION TO THE S-MEPHENYTOIN 4'-HYDROXYLATION PHENOTYPE STATUS, Clinical pharmacology and therapeutics, 61(5), 1997, pp. 574-582
PHARMACOKINETICS OF ANTITUBERCULOSIS DRUGS IN PATIENTS UNDERGOING CAPD
Authors: JANG IJ SHIN SG AHN C SHIN JG SOHN DR KWEON JT KIM HK
Citation: Ij. Jang et al., PHARMACOKINETICS OF ANTITUBERCULOSIS DRUGS IN PATIENTS UNDERGOING CAPD, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 41-41
THE FREQUENCY OF THE 2 MUTATED ALLELES, CYP2C19(M1) AND CYP2C19(M2), IN A KOREAN POPULATION
Authors: KWON JT KIM HK SOHN DR
Citation: Jt. Kwon et al., THE FREQUENCY OF THE 2 MUTATED ALLELES, CYP2C19(M1) AND CYP2C19(M2), IN A KOREAN POPULATION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 81-81
ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY IN A KOREAN POPULATION
Authors: JANG IJ SHIN SG LEE KH YIM DS LEE MS KOO HH KIM HK SOHN DR
Citation: Ij. Jang et al., ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY IN A KOREAN POPULATION, British journal of clinical pharmacology, 42(5), 1996, pp. 638-641
INFLUENCE OF S-MEPHENYTOIN PHENOTYPE ON THE LANSOPRAZOLE METABOLISM
Authors: SOHN DR KWON JT KIM HK
Citation: Dr. Sohn et al., INFLUENCE OF S-MEPHENYTOIN PHENOTYPE ON THE LANSOPRAZOLE METABOLISM, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 34-34
SERUM-INSULIN LEVEL VERSUS BLOOD-PRESSURE - A CROSS-SECTIONAL, CASE-CONTROLLED STUDY IN NONOBESE, MIDDLE-AGED JAPANESE SUBJECTS WITH NORMALGLUCOSE-TOLERANCE
Authors: BABA T KODAMA T TOMIYAMA T SOHN DR ISHIZAKI T
Citation: T. Baba et al., SERUM-INSULIN LEVEL VERSUS BLOOD-PRESSURE - A CROSS-SECTIONAL, CASE-CONTROLLED STUDY IN NONOBESE, MIDDLE-AGED JAPANESE SUBJECTS WITH NORMALGLUCOSE-TOLERANCE, Diabetic medicine, 11(1), 1994, pp. 42-49
S-MEPHENYTOIN PHARMACOGENETICS AND ITS CLINICAL IMPLICATIONS IN ASIANETHNIC POPULATIONS
Authors: SOHN DR SHIN SG ISHIZAKI T
Citation: Dr. Sohn et al., S-MEPHENYTOIN PHARMACOGENETICS AND ITS CLINICAL IMPLICATIONS IN ASIANETHNIC POPULATIONS, Asia Pacific journal of pharmacology, 9(4), 1994, pp. 287-301
INTERETHNIC DIFFERENCES IN OMEPRAZOLE METABOLISM IN THE 2 S-MEPHENYTOIN HYDROXYLATION PHENOTYPES STUDIED IN CAUCASIANS AND ORIENTALS
Authors: ISHIZAKI T SOHN DR KOBAYASHI K CHIBA K LEE KH SHIN SG ANDERSSON T REGARDH CG LOU YC ZHANG Y DAHL ML BERTILSSON L
Citation: T. Ishizaki et al., INTERETHNIC DIFFERENCES IN OMEPRAZOLE METABOLISM IN THE 2 S-MEPHENYTOIN HYDROXYLATION PHENOTYPES STUDIED IN CAUCASIANS AND ORIENTALS, Therapeutic drug monitoring, 16(2), 1994, pp. 214-215
METABOLIC DISPOSITION OF IMIPRAMINE IN ORIENTAL SUBJECTS - RELATION TO METOPROLOL ALPHA-HYDROXYLATION AND S-MEPHENYTOIN 4'-HYDROXYLATION PHENOTYPES
Authors: KOYAMA E SOHN DR SHIN SG CHIBA K SHIN JG KIM YH ECHIZEN H ISHIZAKI T
Citation: E. Koyama et al., METABOLIC DISPOSITION OF IMIPRAMINE IN ORIENTAL SUBJECTS - RELATION TO METOPROLOL ALPHA-HYDROXYLATION AND S-MEPHENYTOIN 4'-HYDROXYLATION PHENOTYPES, The Journal of pharmacology and experimental therapeutics, 271(2), 1994, pp. 860-867
PHARMACOGENETICS OF HUMAN ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY IN A KOREAN POPULATION
Authors: JANG IJ LEE KH SHIN SG PARK CW SOHN DR
Citation: Ij. Jang et al., PHARMACOGENETICS OF HUMAN ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY IN A KOREAN POPULATION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 171-171
Risultati: 1-13 |